HIF1A and breast carcinoma: Our immunohistochemical studies show that HIF-1α and TAZ are remarkably expressed in primary ductal breast carcinoma throughout the neoplastic cells, while in bone metastases their signals are elevated and localized in nuclei, consistent with the role of TAZ as a co-factor of HIF-1 [38].